![Man ultramarathon runner in the mountains he trains at sunset](https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png)
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Cardiovasc. Med. , 13 January 2022
Sec. Cardiovascular Biologics and Regenerative Medicine
Volume 8 - 2021 | https://doi.org/10.3389/fcvm.2021.798091
This article is part of the Research Topic Strategies to Improve Cardiac Function: Novel ideas and future concepts View all 8 articles
A retraction of this article was approved in:
Retraction: STK35 gene therapy attenuates endothelial dysfunction and improves cardiac function in diabetes
Citation: Joladarashi D, Zhu Y, Willman M, Nash K, Cimini M, Thandavarayan RA, Youker KA, Song X, Ren D, Li J, Kishore R, Krishnamurthy P and Wang L (2022) STK35 Gene Therapy Attenuates Endothelial Dysfunction and Improves Cardiac Function in Diabetes. Front. Cardiovasc. Med. 8:798091. doi: 10.3389/fcvm.2021.798091
Received: 19 October 2021; Accepted: 22 December 2021;
Published: 13 January 2022; Retracted: 09 May 2023.
Edited by:
Nicolle Kraenkel, Charité University Medicine Berlin, GermanyReviewed by:
Zhao Wang, City of Hope National Medical Center, United StatesDisclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.